| 000 | 01712 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514185522.0 | ||
| 264 | 0 | _c20041216 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0924-8579 | ||
| 024 | 7 |
_a10.1016/j.ijantimicag.2003.10.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmad, Suhail | |
| 245 | 0 | 0 |
_aContribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cMay 2004 |
||
| 300 |
_a473-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aBacterial Typing Techniques |
| 650 | 0 | 4 |
_aCatalase _xgenetics |
| 650 | 0 | 4 |
_aCodon _xgenetics |
| 650 | 0 | 4 | _aDNA Fingerprinting |
| 650 | 0 | 4 |
_aDNA, Bacterial _xanalysis |
| 650 | 0 | 4 |
_aDeoxyribonuclease HpaII _xmetabolism |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 | _aGenes, Bacterial |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 | _aMiddle East |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aTuberculosis _xmicrobiology |
| 700 | 1 | _aMokaddas, Eiman | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 23 _gno. 5 _gp. 473-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijantimicag.2003.10.004 _zAvailable from publisher's website |
| 999 |
_c14831120 _d14831120 |
||